Search

Home
Research
People
News
Publications
Vacancies
Contact

Guilhem Requirand

Latest

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

© 2025 Cavalli lab. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.

Cite